| | | | | |
BDSX Biodesix, Inc. Common Stock | $21,6800 | -2,12% | $227,72M | $95,59K | |
IRAB Iris Acquisition Corp II | $10,0700 | +1,21% | $227,67M | $6,000 | |
REFI Chicago Atlantic Real Estate Finance, Inc. Common Stock | $10,8300 | +1,31% | $227,63M | $70,60K | |
SMTI Sanara MedTech Inc. Common Stock | $23,7750 | -0,44% | $227,63M | $62,82K | |
SABA Saba Capital Income & Opportunities Fund II | $8,1800 | -0,24% | $227,54M | $92,47K | |
CRAC Crown Reserve Acquisition Corp. I Class A Ordinary Shares | $10,1050 | -0,15% | $226,14M | $19,60K | |
NPV Nuveen Virginia Quality Municipal Income Fund | $11,4100 | -0,18% | $225,55M | $36,85K | |
OPBK OP Bancorp Common Stock | $14,8600 | +1,30% | $225,49M | $12,90K | |
PNNT Pennant Investment Corp | $3,4400 | +1,18% | $225,27M | $482,60K | |
AOMR Angel Oak Mortgage REIT, Inc. | $9,0100 | +0,78% | $225,22M | $63,79K | |
| $2,4200 | -5,47% | $224,51M | $495,13K | |
| $6,7500 | +3,69% | $224,42M | $348,35K | |
CHRS Coherus Oncology, Inc. Common Stock | $1,5500 | -4,91% | $223,66M | $867,22K | |
KROS Keros Therapeutics, Inc. Common Stock | $11,8100 | -1,83% | $222,85M | $225,89K | |
QTTB Q32 Bio Inc. Common Stock | $15,9500 | +26,69% | $221,95M | $698,61K | |
